BellaSeno’s 3D-printed Resorbable Scaffold Successfully Used in Critical-Size Large Segmental Radius Bone Defect at Hannover Medical School
March 05, 2024 04:00 ET
|
AKAMPION
-- Trauma patient suffered from third degree open infected fracture of its radial shaft after injury by a bullet -- Graft vascularization was achieved by embedding vascular pedicle into the scaffold ...
New investigator-initiated clinical trials of BellaSeno´s resorbable tissue regeneration scaffolds to be conducted in Europe
January 31, 2024 04:00 ET
|
AKAMPION
New clinical trial site opened in Italy for pectus excavatum and planned in Germany for bone reconstructionCompany aims to expand EU market authorization from custom-made to off-the-shelf products and...
BellaSeno Presents Novel Production Workflow for Customized, 3D-Printed Bone Scaffolds
October 30, 2023 05:00 ET
|
AKAMPION
Presentation at the German Congress of Orthopaedics and Traumatology (DKOU)Treatment of large segmental bone defects with resorbable scaffoldsLeading-edge workflow for the design and manufacturing of...
BellaSeno Demonstrates Superior Biomechanical Properties of its 3-D Printed, Resorbable Scaffolds for Bone Reconstruction
June 20, 2023 04:00 ET
|
AKAMPION
Data presented at the 24th EFFORT Congress in Vienna (Austria) Leipzig, Germany, June 20, 2023 – BellaSeno GmbH, an ISO 13485-certified medtech company developing resorbable scaffolds using...
Novadip Biosciences announces EUR 19 million Series B financing backed by international investors
October 28, 2021 07:00 ET
|
Novadip Biosciences
Novadip Biosciences announces EUR 19 million Series B financing backed by international investors New investment to fuel continued growth of 3M³ platform for the development of products in tissue...
Novadip Biosciences announces EUR 19 million Series B financing backed by international investors
October 28, 2021 01:00 ET
|
Novadip Biosciences
Novadip Biosciences announces EUR 19 million Series B financing backed by international investors New investment to fuel continued growth of 3M³ platform for the development of products in tissue...